Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT05136807
Status
Recruiting
Apply to this trial

Conditions

  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quality-of-Life Assessment — OTHER
    Complete questionnaires
  • Questionnaire Administration — OTHER
    Complete questionnaires

Study Details

This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from patients may help doctors learn more about the most common symptoms and concerns patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma may have.

Key Dates

Start date
Jun 7, 2016
Status verified
Apr 2026
Primary completion
Feb 2, 2027
Completion
Feb 2, 2027

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Observational (quality of life questionnaire)
    Patients complete quality of life questionnaires over 10-15 minutes at baseline and every 6 months for patients participating in an observational study or every month for patients participating in a treatment study for up to 3 years.

Primary Outcome Measure

Quality of life questionnaires [ Time Frame: Up to 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Mei Huang
[email protected]
713-745-9901
Elisabet E. Manasanch (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies